Skip to main content

Key Insights: Treating Acute Myeloid Leukemia (AML)

May 28, 2026

Topics:  

This patient education program covers:

  • Treatment advances for AML
  • Approaches to lessen or cope with treatment side effects
  • Ways to talk with your care team about your needs and daily well-being

Speaker

Tapan Kadia, MD
Professor, Department of Leukemia
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, TX

Program Materials

  • Slides
  • Transcript will be available soon

Program Support

This program is supported by Astellas Pharma US Inc., Genentech, a member of the Roche Group, and Kura Oncology, Inc. 

 

< Back to Webcasts

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.